Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Return on Invested Capital (2019 - 2022)

Regenxbio has reported Return on Invested Capital over the past 4 years, most recently at 0.15% for Q4 2022.

  • Quarterly results put Return on Invested Capital at 0.15% for Q4 2022, down 8.0% from a year ago — trailing twelve months through Dec 2022 was 0.15% (down 8.0% YoY), and the annual figure for FY2023 was 0.65%, down 78.0%.
  • Return on Invested Capital for Q4 2022 was 0.15% at Regenxbio, down from 0.15% in the prior quarter.
  • Over the last five years, Return on Invested Capital for RGNX hit a ceiling of 15.68% in Q4 2019 and a floor of 17.43% in Q4 2020.
  • Median Return on Invested Capital over the past 4 years was 0.3% (2021), compared with a mean of 0.26%.
  • Biggest five-year swings in Return on Invested Capital: plummeted -3311bps in 2020 and later skyrocketed 1766bps in 2021.
  • Regenxbio's Return on Invested Capital stood at 15.68% in 2019, then plummeted by -211bps to 17.43% in 2020, then soared by 101bps to 0.24% in 2021, then tumbled by -36bps to 0.15% in 2022.
  • The last three reported values for Return on Invested Capital were 0.15% (Q4 2022), 0.15% (Q3 2022), and 0.16% (Q2 2022) per Business Quant data.